Global Epigenetics Market for Therapeutics, Research & Development Growth, Trends and Forecasts (2017 - 2022)

The epigenetics market, valued as a USD 1.7 billion market in 2012, is expected to become a USD 7 billion market by 2018, showing a CAGR as high as 26.72%.



Epigenetics is the study of changes in gene expression caused by certain base pairs in DNA, or RNA, being turned off" or "turned on" again

1. INTRODUCTION

1.1 Report Description

1.2 Research Methodology

1.3 Stakeholders

2. EXECUTIVE SUMMARY

2.1 Key Findings

2.2 Market Overview

3. MARKET OVERVIEW

3.1 Market Definition

3.1.1 Introduction

3.2 Market Drivers

3.2.1 Global Cancer

3.2.2 Wide range of applications

3.2.3 Increasing investments & funds

3.3 Market Restraints

3.3.1 Lack of Reimbursement plans

3.3.2 Lack of predictive markers

4. GLOBAL MARKETS: SEGMENTATION BY THERAPEUTICS, RESEARCH & DIAGNOSTICS

4.1 Therapeutics

4.1.1 Oncology Conditions

4.1.2 Non-Oncology Indications

4.1.3 Personalized Medicine

4.2 Research & Diagnostics

4.2.1 Gene Regulation Studies

4.2.2 Biomarker Detections

4.2.3 Drug Discovery

5. GLOBAL MARKETS: SEGMENTATION BY GEOGRAPHY

5.1 North America

5.1.1 USA

5.1.2 Canada

5.1.3 Mexico

5.2 Europe

5.2.1 UK

5.2.2 Germany

5.2.3 France

5.2.4 Spain

5.3 APAC

5.3.1 India

5.3.2 China

5.3.3 Japan

5.3.4 South Korea

6. COMPETITVE LANDSCAPE

6.1 Introduction

6.2 Mergers & Acquisitions

6.3 Expansions

6.4 New Product Launch

6.5 Collaborations

7. COMPANY PROFILES

7.1 4SC

7.2 Celgene

7.3 Cellcentric

7.4 Covaris Inc.

7.5 Epiontis

7.6 Epitherapeutics

7.7 Epizyme

7.8 Karus Therpeutics

7.9 Merck Millipore

7.10 Ribimed Biotechnologies

8. Appendix

Content are not available

Choose License Type